Outcomes of Allogeneic Stem Cell Transplant (Allo-SCT) for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) in Patients Older Than 75 Years: A Single Center Analysis

被引：0
|
作者：
Nath, Rajneesh [1 ]
Cerny, Jan [2 ]
Ramanathan, Muthalagu [3 ]
Zhou, Zheng [2 ]
Yu, Neng [4 ]
Raffel, Glen D. [5 ]
Bednarik, Jayde [6 ]
机构：
[1] Banner MD Anderson Canc Ctr, Div Hematol Oncol, BMT & Acute Leukemia Program, Gilbert, AZ USA
[2] Univ Massachusetts, Med Sch, Dept Med, Div Hematol Oncol, Worcester, MA USA
[3] Univ Massachusetts Mem Ctr, Div Hematol, Dept Internal Med, Worcester, MA USA
[4] UMass Mem Med Ctr, HLA Lab, Worcester, MA USA
[5] Univ Massachusetts Med Sch, Div Hematol Oncol, Worcester, MA USA
[6] UMass Mem Med Ctr, Worcester, MA USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.5875.5875
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5875
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Prognostic Impact of Variant Allelic Frequency of Molecular Mutations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) on Allogeneic Hematopoietic Cell Transplant (HCT) Outcomes
    Hamilton, Betty Ky
    Majhail, Navneet S.
    Hirsch, Cassandra
    Przychodzen, Bartolmiej
    Rybicki, Lisa
    Kalaycio, Matt E.
    Bolwell, Brian
    Gerds, Aaron
    Sobecks, Ronald M.
    Hanna, Rabi
    Sekeres, Mikkael
    Maciejewski, Jaroslaw
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S71 - S71
  • [32] UNRELATED DONOR (UD) ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) IN PRIMARY REFRACTORY ACUTE MYELOID LEUKEMIA (AML): REPORT OF 381 PATIENTS FROM THE ACUTE LEUKEMIA WORKING PARTY OF EBMT
    Brissot, E.
    Labopin, M.
    Stelljes, M.
    Ehninger, G.
    Schwerdtfeger, R.
    Zander, A. R.
    Mielke, S.
    Ganser, A.
    Finke, J.
    Schufer-Eckart, K.
    Bunjes, D.
    Kroeger, N.
    Schmid, C.
    Bethge, W. A.
    Kolb, H. J.
    Blau, I. W.
    Vitek, A.
    Bochtler, T.
    Meyer, R. G.
    Holler, E.
    Esteve, J.
    Nagler, A.
    Mohty, M.
    HAEMATOLOGICA, 2015, 100 : 13 - 14
  • [33] The role of reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (ALLO-SCT) in patients with acute myeloid leukemia (AML): A donor versus no donor comparison
    De Lavallade, H
    Mohty, M
    Faucher, C
    Vey, N
    Coso, D
    Stoppa, AM
    Gastaut, JA
    Ladaique, P
    Chabannon, C
    Blaise, D
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 3 - 3
  • [34] Feasibility and efficacy of allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia (AML) or poor prognosis myelodysplastic syndrome (MDS): A single center experience
    Crotta, A.
    Tassara, M.
    Peccatori, J.
    Assanelli, A.
    Corti, C.
    Calbi, V
    Lupo, Stanghellini M. T.
    Guggiari, E.
    Ciceri, F.
    Bernardi, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 217 - 217
  • [35] Immune Recovery (IR) Following allogeneic Stem Cell Transplant (Allo-SCT): A Comparison of Three Different Transplant Strategies at a Single Transplant Center
    Al-Mansour, Zeina
    George, Mridula
    Zhou, Zheng
    Raffel, Glen
    Petrillo-Deluca, Laura
    Shanahan, Lindsey
    Yu, Hongbo
    Woda, Bruce A.
    Ramanathan, Muthalagu
    Cerny, Jan
    Nath, Rajneesh
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S167 - S168
  • [36] REDUCED INTENSITY CONDITIONING (RIC) ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML): LONG TERM RESULTS OF A DONOR vs NO DONOR COMPARISON
    Mohty, M.
    De Lavallade, H.
    El-Cheikh, J.
    Ladaique, P.
    Faucher, C.
    Fuerst, S.
    Vey, N.
    Coso, D.
    Stoppa, A. M.
    Gastaut, J. A.
    Chabannon, C.
    Blaise, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 14 - 14
  • [37] Dose reduced conditioning and allogeneic stem cell transplantation in 36 patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
    Bornhäuser, M
    Schaich, M
    Schaekel, U
    Mahlberg, R
    Clemens, M
    Ehninger, G
    BONE MARROW TRANSPLANTATION, 2001, 27 : S85 - S85
  • [38] Comprehensive Analysis of Safety: Rigosertib in 557 Patients with Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
    Garcia-Manero, Guillermo
    Fenaux, Pierre
    Al-Kali, Aref
    Navada, Shyamala C.
    Baer, Maria R.
    Raza, Azra
    Greenberg, Peter
    Kreuzer, Karl-Anton
    Hiwase, Devendra K.
    Roboz, Gail J.
    Santini, Valeria
    Platzbecker, Uwe
    Petrone, Michael E.
    Brownstein, Bernard
    Zbyszewski, Patrick Simon
    Maniar, Manoj
    Silverman, Lewis R.
    BLOOD, 2016, 128 (22)
  • [39] Stem cell transplantation (SCT) for acute myeloid leukemia (AML): A single center in over 25 years experience.
    Santarone, Stella
    Di Bartolomeo, Erminia
    Di Bartolomeo, Paolo
    BLOOD, 2006, 108 (11) : 430B - 430B
  • [40] Dose reduced conditioning and allogeneic stem cell transplantation in 34 patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Bornhauser, M
    Kroschinsky, F
    Ulrike, S
    Markus, S
    Eberhard, S
    Ralph, N
    Thiede, C
    Ulrich, S
    Gerhard, E
    BLOOD, 2000, 96 (11) : 780A - 780A
12345